ZA892412B - Method of preventing or reducing adverse reactions to protamine using a thromboxane a2 receptor antagonist - Google Patents

Method of preventing or reducing adverse reactions to protamine using a thromboxane a2 receptor antagonist

Info

Publication number
ZA892412B
ZA892412B ZA892412A ZA892412A ZA892412B ZA 892412 B ZA892412 B ZA 892412B ZA 892412 A ZA892412 A ZA 892412A ZA 892412 A ZA892412 A ZA 892412A ZA 892412 B ZA892412 B ZA 892412B
Authority
ZA
South Africa
Prior art keywords
thromboxane
protamine
preventing
receptor antagonist
adverse reactions
Prior art date
Application number
ZA892412A
Other languages
English (en)
Inventor
Martin L Ogletree
L Ogletree Martin
William A Schumacher
A Schumacher William
Gary J Grover
J Grover Gary
Lawrence T Friedhoff
T Friedhoff Lawrence
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ZA892412B publication Critical patent/ZA892412B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
ZA892412A 1988-04-11 1989-03-31 Method of preventing or reducing adverse reactions to protamine using a thromboxane a2 receptor antagonist ZA892412B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/179,694 US5066480A (en) 1988-04-11 1988-04-11 Method of preventing or reducing adverse reactions to protamine using a thromboxane a2 receptor antagonist

Publications (1)

Publication Number Publication Date
ZA892412B true ZA892412B (en) 1990-01-31

Family

ID=22657593

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA892412A ZA892412B (en) 1988-04-11 1989-03-31 Method of preventing or reducing adverse reactions to protamine using a thromboxane a2 receptor antagonist

Country Status (12)

Country Link
US (1) US5066480A (de)
EP (1) EP0337697B1 (de)
JP (1) JPH0296537A (de)
AT (1) ATE92323T1 (de)
AU (1) AU624370B2 (de)
CA (1) CA1336953C (de)
DE (1) DE68907976T2 (de)
DK (1) DK170989A (de)
HU (1) HU206261B (de)
IE (1) IE63735B1 (de)
NZ (1) NZ228491A (de)
ZA (1) ZA892412B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69329333D1 (de) * 1992-03-20 2000-10-05 Cor Therapeutics Inc Durch glykosylierung vermittelte hemmung des faktors x
US7356737B2 (en) * 2004-10-29 2008-04-08 International Business Machines Corporation System, method and storage medium for testing a memory module
US9693998B2 (en) 2014-05-16 2017-07-04 Cumberland Pharmaceuticals, Inc. Compositions and methods of treating cardiac fibrosis with ifetroban
US12161632B2 (en) 2014-05-16 2024-12-10 Cumberland Pharmaceuticals Inc. Compositions and methods of treating cardiac fibrosis with ifetroban
AU2016285566A1 (en) 2015-06-30 2017-12-14 Cumberland Pharmaceuticals, Inc. Thromboxane receptor antagonists in AERD/asthma
EP3454850B1 (de) 2016-05-11 2023-06-21 Cumberland Pharmaceuticals Inc. Zusammensetzungen und verfahren zur behandlung von muskeldystrophie mit thromboxan-a2-rezeptor-antagonisten
JP7305197B2 (ja) 2017-11-29 2023-07-10 ヴァンダービルト ユニバーシティー 腫瘍転移を阻害する方法
US11494695B2 (en) 2019-09-27 2022-11-08 Google Llc Training neural networks to generate structured embeddings

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
ZA827529B (en) * 1981-11-09 1983-09-28 Squibb & Sons Inc 7-oxabicycloheptane and 7-oxabicycloheptene compounds
US4416896A (en) * 1982-05-17 1983-11-22 E. R. Squibb & Sons, Inc. 7-Oxabicyclopheptane substituted amino prostaglandin analogs useful in the treatment of thrombolytic disease
EP0153858A3 (de) * 1984-02-29 1985-12-11 The Upjohn Company Therapeutische Anwendung von Protaglandinen
US4663336A (en) * 1985-07-01 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted diamide and its congener prostaglandin analogs useful in the treatment of thrombotic disease

Also Published As

Publication number Publication date
IE63735B1 (en) 1995-06-14
DK170989D0 (da) 1989-04-10
HUT52372A (en) 1990-07-28
AU3269189A (en) 1989-10-12
DK170989A (da) 1989-10-12
CA1336953C (en) 1995-09-12
IE891061L (en) 1989-10-11
ATE92323T1 (de) 1993-08-15
NZ228491A (en) 1997-03-24
EP0337697A2 (de) 1989-10-18
EP0337697B1 (de) 1993-08-04
DE68907976T2 (de) 1994-03-31
AU624370B2 (en) 1992-06-11
EP0337697A3 (en) 1990-08-16
JPH0296537A (ja) 1990-04-09
US5066480A (en) 1991-11-19
HU206261B (en) 1992-10-28
DE68907976D1 (de) 1993-09-09

Similar Documents

Publication Publication Date Title
AU3264489A (en) 2-substituted-4-substituted-1,3-dioxalanes, synthesis and use thereof
AU5486894A (en) Process for producing solid organo-aluminoxy compounds useful in polymerization catalysts
AU570142B2 (en) Purine derivatives
EP0337697A3 (en) Method of preventing or reducing adverse reactions to protamine using a thromboxane a2 receptor antagonist
DE68922235D1 (de) Durch Acetylen, Cyan oder Allen substituierte Aristeromycin- oder Adenosin-Derivate.
ES2000368A6 (es) Un procedimiento para preparar di-t-butilfenoles sustituidos
GR3024588T3 (en) Use of modified heparin cofactor II
AU584796B2 (en) Deactivation of phosphonium salt catalyst
AU3896485A (en) Oxygen absorption by molten alkali metal salts
FI894121A0 (fi) 2-atsa-4-(alkoksikarbonyyli)spiro/4,5/dekan-3-oni
EP0335416A3 (de) Modifiziertes Polyoxytetramethylenglykol und Verfahren zu seiner Herstellung
GB1483158A (en) Preparation of cyclododecatriene
EP0240890A3 (en) Prostacyclin (pgi2) analogues
JPS5318313A (en) Encoding system
PH19941A (en) Isothiourea derivatives
NZ212870A (en) A process for the preparation of 1,3-dihydro-4-pyridoyl-2h-imidazol-2-ones and intermediates therefor
DK423186A (da) Spiro-(benzofuran-2(3h),1`cycloheptan)-derivater, deres fremstilling og anvendelse samt mellemprodukt til fremstillingen
ATE70265T1 (de) 2-aza-4-(alkoxycarbonyl)spiro-(4,5>decan-3-on.
AU7839691A (en) Process for the production of 1,1,1,2-tetrafluoroethane
FR2603577A1 (fr) Procede de conversion du methane en hydrocarbures superieurs
GB1497723A (en) Octahydrobenzo-(c)(1,6)-naphthyridine derivative
IT1203879B (it) Procedimento per la preparazione di (+)-13-norfaranale
HUT42081A (en) Process for preparing 2,3-dichloro-thiophene
AU2602184A (en) Epoxydation of ethylene with butyl hydroperoxide using as catalysts metal complexes of hoarch=nr
RO92553B1 (ro) Compozitie de acoperire pentru consolidarea suporturilor de zidarie